CL2014002244A1 - Proceso para mejorar la eficiencia de alimentación y características de la canal de los animales, que comprende tratar al animal con una composicion que contiene desde 2 a 76% en peso de al menos un triglicerido con al menos un acido graso hidroxilado y 24 a 95% de liquido de la cascara de nuez de anacardo. - Google Patents

Proceso para mejorar la eficiencia de alimentación y características de la canal de los animales, que comprende tratar al animal con una composicion que contiene desde 2 a 76% en peso de al menos un triglicerido con al menos un acido graso hidroxilado y 24 a 95% de liquido de la cascara de nuez de anacardo.

Info

Publication number
CL2014002244A1
CL2014002244A1 CL2014002244A CL2014002244A CL2014002244A1 CL 2014002244 A1 CL2014002244 A1 CL 2014002244A1 CL 2014002244 A CL2014002244 A CL 2014002244A CL 2014002244 A CL2014002244 A CL 2014002244A CL 2014002244 A1 CL2014002244 A1 CL 2014002244A1
Authority
CL
Chile
Prior art keywords
animal
triglyceride
fatty acid
improve
weight
Prior art date
Application number
CL2014002244A
Other languages
English (en)
Inventor
Joan Torrent Campmany
Original Assignee
Oligo Basics Agroindustrial Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oligo Basics Agroindustrial Ltda filed Critical Oligo Basics Agroindustrial Ltda
Publication of CL2014002244A1 publication Critical patent/CL2014002244A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/30Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/22Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
CL2014002244A 2012-02-23 2014-08-22 Proceso para mejorar la eficiencia de alimentación y características de la canal de los animales, que comprende tratar al animal con una composicion que contiene desde 2 a 76% en peso de al menos un triglicerido con al menos un acido graso hidroxilado y 24 a 95% de liquido de la cascara de nuez de anacardo. CL2014002244A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/385,521 US20130224320A1 (en) 2012-02-23 2012-02-23 Process to improve feed efficiency and carcass characteristics of animals

Publications (1)

Publication Number Publication Date
CL2014002244A1 true CL2014002244A1 (es) 2015-04-10

Family

ID=49003124

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014002244A CL2014002244A1 (es) 2012-02-23 2014-08-22 Proceso para mejorar la eficiencia de alimentación y características de la canal de los animales, que comprende tratar al animal con una composicion que contiene desde 2 a 76% en peso de al menos un triglicerido con al menos un acido graso hidroxilado y 24 a 95% de liquido de la cascara de nuez de anacardo.

Country Status (18)

Country Link
US (1) US20130224320A1 (es)
EP (1) EP2819678B1 (es)
JP (1) JP6092899B2 (es)
KR (1) KR102069910B1 (es)
CN (1) CN104203248A (es)
AU (1) AU2013222795B2 (es)
BR (1) BR112014020782B1 (es)
CA (1) CA2862938C (es)
CL (1) CL2014002244A1 (es)
ES (1) ES2710401T3 (es)
HK (1) HK1204270A1 (es)
IN (1) IN2014MN01497A (es)
MX (1) MX2014010222A (es)
MY (1) MY180916A (es)
PE (1) PE20142247A1 (es)
SG (1) SG11201404591QA (es)
WO (1) WO2013126149A1 (es)
ZA (1) ZA201405510B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10624365B2 (en) * 2013-10-09 2020-04-21 Nutrition Sciences N.V. Composition of medium-chain fatty acids and feed supplemented with composition
JP6690810B2 (ja) * 2015-01-30 2020-04-28 出光興産株式会社 機能性飼料
CN108697123B (zh) * 2016-02-12 2023-02-28 日本史迪士生物科学株式会社 功能性饲料
MX2020007211A (es) * 2017-12-18 2020-09-07 Integene Pty Ltd Aditivo de agua y composicion.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427802A (en) * 1991-10-09 1995-06-27 Cbp Resources, Inc. Process for enhancing the growth performance of edible meat-producing animals
ZA933256B (en) * 1992-05-11 1993-11-29 Commomwealth Scient And Ind Re Feed conversion
US6022566A (en) * 1997-12-02 2000-02-08 Balchem Corporation Method for increasing the feed intake, feed efficiency, daily gain and/or carcass grade in ruminants
PL355669A1 (en) * 1999-11-15 2004-05-04 Eli Lilly And Company Aryloxy propanolamines for improving livestock production
JP4680339B2 (ja) * 1999-11-26 2011-05-11 日清丸紅飼料株式会社 コクシジウム症の予防および/または治療用飼料
KR20020060577A (ko) * 2000-07-07 2002-07-18 아키라 이가키 비만 억제제
BRPI0700927B8 (pt) * 2007-03-16 2021-05-25 Oligo Basics Agroindustrial Ltda composição antimicrobiana
ES2406423T3 (es) 2007-06-08 2013-06-06 Idemitsu Kosan Co., Ltd. Agente de control de la distensión abdominal para animales rumiantes
ES2749386T3 (es) * 2008-06-09 2020-03-20 Idemitsu Kosan Co Composición para pienso, y pienso que comprende la misma
DK2397147T3 (en) * 2008-12-12 2015-08-03 Idemitsu Kosan Co The feed for the prevention and / or treatment of diseases caused by clostridium bacteria in cattle as well as anti-Clostridium agent
JPWO2010113886A1 (ja) * 2009-03-30 2012-10-11 出光興産株式会社 家畜の増体促進剤、増体促進飼料および増体促進方法

Also Published As

Publication number Publication date
WO2013126149A1 (en) 2013-08-29
CN104203248A (zh) 2014-12-10
JP6092899B2 (ja) 2017-03-08
IN2014MN01497A (es) 2015-04-17
HK1204270A1 (en) 2015-11-13
AU2013222795A1 (en) 2014-09-18
ZA201405510B (en) 2016-06-29
KR102069910B1 (ko) 2020-01-23
EP2819678B1 (en) 2018-11-07
BR112014020782A2 (pt) 2020-10-27
PE20142247A1 (es) 2014-12-27
EP2819678A4 (en) 2016-02-17
JP2015509367A (ja) 2015-03-30
US20130224320A1 (en) 2013-08-29
SG11201404591QA (en) 2014-09-26
MX2014010222A (es) 2015-07-06
CA2862938C (en) 2019-08-20
BR112014020782B1 (pt) 2022-06-21
ES2710401T3 (es) 2019-04-24
MY180916A (en) 2020-12-12
EP2819678A1 (en) 2015-01-07
KR20140127899A (ko) 2014-11-04
CA2862938A1 (en) 2013-08-29
AU2013222795B2 (en) 2015-12-24

Similar Documents

Publication Publication Date Title
CL2011002745A1 (es) Compuestos derivados de acidos grasos poliinsaturados; metodo de preparacion; composicion farmaceutica que los comprende; y su uso para la prevencion o el tratamiento de trastornos cardiovasculares, metabolicos e inflamatorios, tales como, artritis reumatoide, aterosclerosis, diabetes, dislipidemia, entre otras.
BR112017009043A2 (pt) processo para formar uma composição de combustível sólida a partir de resíduos sólidos misturados
CL2014003475A1 (es) Forma c cristalina de acido obeticolico; proceso de preparacion de la forma 1 de acido obeticolico a partir de la forma c cristalina; composicion farmaceutica que comprende a una forma cristalina de acido obeticolico, util para el tratamiento o prevencion de una enfermedad hepatica colestasica, hepatopatia alcoholica y enfermedades cardiovasculares tal como aterosclerosis, entre otras.
SG10201809290SA (en) Compositions and Methods to Treating Hemoglobinopathies
BR112014005400A2 (pt) método para aumentar o crescimento de uma planta, e, composição
CL2013002612A1 (es) Compuestos derivados de c4-monometil triterpenoides; composicion farmaceutica que los comprende; y metodo para tratar o prevenir una enfermedad o un trastorno.
EP2935594A4 (en) PROCESS FOR INCREASING FAT / OIL CONTENT IN PLANTS
MX2016008270A (es) Lipido que comprende acidos grasos poliinsaturados de cadena larga.
AR088762A1 (es) Proceso para producir un producto acrilato
CL2012002897A1 (es) Metodo que comprende procesar biomasa microbiana interrumpida no tratada que tiene una composicion de aceite y fraccionar el extracto obtenido para obtener una composicion lipidica de al menos un acido graso poliinsaturado.
CL2015000956A1 (es) Compuestos derivados de pirrolotriazinona como inhibidores de pi3k; composicion farmaceutica que los comprende; combinacion farmaceutica; uso para tratar enfermedades respiratorias, autoinmunes, trastornos neurologicos, cardiovasculares, metabolicos, entre otros.
DOP2014000048A (es) Composiciones farmacéuticas que comprenden un polisacárido y un inhibidor hdac
BR112014022814A2 (pt) catalisador ácido sólido, método de produção do mesmo e método de produção de alquil éster de ácido graxo utilizando o mesmo
CL2014001385A1 (es) Metodo y composicion para aumentar la proporcion de ingredientes dietarios que son resistentes a la degradacion por los microorganismos del rumen
MX2013014421A (es) Procedimiento para la preparacion de una composicion que comprende complejos metalicos en una matriz organica aceitosa.
CL2012000316A1 (es) Compuestos fungicidas derivados de n1-acil-5-fluoro-pirimidinona; composiciones que los comprenden y metodo que los emplea para combatir hongos fitopatogenos.
EP2831234A4 (en) COMPOSITIONS, PROCESSES, AND PLANT GENES TO IMPROVE THE PRODUCTION OF FERMENTABLE SUGARS FOR THE MANUFACTURE OF BIOFUEL
CL2014002244A1 (es) Proceso para mejorar la eficiencia de alimentación y características de la canal de los animales, que comprende tratar al animal con una composicion que contiene desde 2 a 76% en peso de al menos un triglicerido con al menos un acido graso hidroxilado y 24 a 95% de liquido de la cascara de nuez de anacardo.
IL246254B (en) Compounds of omega-3 fatty acids for the treatment of diseases involving damage to the nervous system
CL2015002650A1 (es) Métodos y composiciones para aumentar la eficacia de la modificación génica, dirigida utilizando reparación génica mediada por oligonucleótidos.
SG11201408731WA (en) USE OF 2-METHYLENE-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D<sb>3</sb> TO TREAT SECONDARY HYPERPARATHYROIDISM
CL2014000482A1 (es) Metodo para eliminar los microorganismos de material vegetal
AR101136A1 (es) Proceso para la preparación de ácidos 3-hidroxipicolínicos
AR077196A1 (es) Champu concentrado
PE20151879A1 (es) Proceso para la fabricacion de productos a partir de fibra de madera acetilada